PSA testing in Ontario: OHIP coverage and informed choice

Since April 2026, Ontario’s laboratory requisition has explained more clearly when a prostate-specific antigen, or PSA, test may be insured by OHIP. The change is useful, but it does not make screening automatic, free for everyone or appropriate in every situation. Coverage, the decision to test and interpretation of the result are three separate questions.

Ontario’s 2026 requisition clarifies when PSA testing may be OHIP-insured; it does not expand eligibility. Discuss your risk, the test’s limits, possible cost and the follow-up plan before testing. (Read more)

1. What changed on the 2026 requisition

Ontario’s Ministry of Health revised the form wording effective April 16, 2026. It now explains that testing may be insured when a clinician suspects prostate cancer based on factors such as family history, ancestry or race, a physical examination or symptoms, and for monitoring someone already diagnosed with prostate cancer. Screening in a person without symptoms is identified as uninsured. The Ministry says the wording did not change the coverage criteria; it made them more visible.

2. Coverage and clinical fit are different questions

Being eligible for coverage does not automatically make the test the right choice, and paying privately does not automatically make it unnecessary. Ontario advises people to discuss personal risk with a doctor or nurse practitioner. Canadian guidance is not perfectly uniform: the Canadian Cancer Society suggests a risk- and age-informed discussion, while the Canadian Task Force recommends against routine screening and emphasizes shared decision-making for some adults. That difference is a reason to discuss your context, not to choose a test from an online headline.

3. What a PSA test can — and cannot — show

PSA is a protein measured in the blood. A higher level can be associated with prostate cancer, but non-cancerous causes can also raise it. A result within the expected range does not completely exclude cancer. The test may lead to repeat testing, other investigations or monitoring, but it does not establish a diagnosis on its own. Before the blood draw, ask what the result could change and what follow-up is planned for a high, uncertain or discordant result.

4. Prepare a useful request before the consultation

Have your age, personal history, any family history of prostate cancer, previous PSA results, urinary changes or other symptoms that concern you, and relevant recent medications or procedures ready. Do not try to decide for yourself whether the test should be insured. Describe why you are asking so the clinician can assess the clinical fit and complete the requisition accurately.

5. Confirm the cost and who owns follow-up

For asymptomatic screening that does not meet OHIP criteria, the laboratory may charge for the test. Confirm the fee directly with the lab before collection. If you use MedVibe, its consultation fee covers clinical review; laboratory fees are separate. After a request, the clinician may decide not to issue a requisition; OHIP or the laboratory then determines the applicable coverage. Also ask who will receive the result, when you should check back and how an important result will be communicated.

6. A sound decision includes what happens after the test

A good conversation does not end with a yes or no to the blood draw. It covers your risk level, what you hope to learn, the possibility of a false signal, the next step after an abnormal result and your preferences about further testing. If those points are unclear, ask for an explanation before paying or going to the laboratory.

This guide provides general information and does not recommend PSA testing for any individual. It does not replace a clinical assessment, official OHIP criteria or laboratory instructions. A requisition, coverage, diagnosis, follow-up or result is never guaranteed. For non-urgent health advice in Ontario, call 811. For severe pain, inability to urinate, heavy bleeding, serious illness or another emergency, call 911 or go to an emergency department.